Atopic Dermatitis study: TRIV-573
Official title A Study Evaluating TRIV-573 in Atopic Dermatitis
ClinicalTrials.gov ID: NCT07782333
What this study is testing
What is TRIV-573?
TRIV-573 is an investigational injectable medicine being studied to treat moderate to severe atopic dermatitis in adults.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to see if TRIV‑573 helps adults with moderate to severe atopic dermatitis and to check its safety.
- Who it's for
- Adults with moderate to severe atopic dermatitis.
- What's involved
- Participants will receive either TRIV‑573 or a placebo, given in five doses, and will attend study visits for monitoring and tests.
- Time commitment
- The study lasts up to 40 weeks, including a screening period of up to 30 days, with several scheduled visits during that time.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Has Atopic Dermatitis.
- Has moderate to severe, active and symptomatic atopic dermatitis.
You likely can't join if
- Severe or uncontrolled medical conditions.
- Use of prohibited medications within stated washout periods.
The study team makes the final eligibility decision.
Where it is enrolling
- Fountain Valley, California, United States
- Los Angeles, California, United States
- Boca Raton, Florida, United States
- Miami, Florida, United States
- Indianapolis, Indiana, United States
- Bay City, Michigan, United States
- Boardman, Ohio, United States
- Camp Hill, Pennsylvania, United States
- Myrtle Beach, South Carolina, United States
- San Antonio, Texas, United States
- Spokane, Washington, United States
- Calgary, Alberta, Canada
- Barrie, Ontario, Canada
- Ivano-Frankivsk, Ukraine
- Kyiv, Ukraine
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Fountain Valley, California, United States; Los Angeles, California, United States; Boca Raton, Florida, United States; Miami, Florida, United States; Indianapolis, Indiana, United States; Bay City, Michigan, United States and 9 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.